Study to Assess the Effect of OXYJUN on Ejection Fraction and Markers of Cardiovascular Injury

NCT02207101 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Vedic Lifesciences Pvt. Ltd.

Collaborators